The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...
20, the FDA announced that the agency has approved Eli Lilly's Zepbound ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the ...
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...